FdaApplication
ANDA 202376
Identifiers
- fda_app_no: ANDA202376
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2013-11-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RABEPRAZOLE SODIUM | RABEPRAZOLE SODIUM | 20MG | TABLET, DELAYED RELEASE;ORAL |
1 product